Literature DB >> 20734417

Opioid system functional regulation in neurological disease management.

M S Nandhu1, George Naijil, Soman Smijin, S Jayanarayanan, C S Paulose.   

Abstract

There is increasing evidence to suggest a role for the opioid system in the control of pathophysiology of neurological disorders (Alzheimer's, Parkinson's, and Huntington's diseases, spinal cord injury, epilepsy, hypoxia, and autism). Resuscitation of the altered expression of the opioid system in various neurological disorders is of therapeutic importance. Such treatment may be beneficial in ameliorating the clinical symptoms of the disorder. This Mini-Review provides a brief update on opioid system regulation in neurological disorders and focuses on the opioids' pharmacological importance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20734417     DOI: 10.1002/jnr.22463

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Exploring the enkephalinergic differentiation potential in adult stem cells for cell therapy and drug screening implications.

Authors:  Maryam Hafizi; Behnaz Bakhshandeh; Masoud Soleimani; Amir Atashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-10-06       Impact factor: 2.416

Review 2.  Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.

Authors:  Xiaozhou He; Harleen K Sandhu; Yilin Yang; Fei Hua; Nathalee Belser; Dong H Kim; Ying Xia
Journal:  Cell Mol Life Sci       Date:  2012-09-27       Impact factor: 9.261

3.  Distinct Synaptic Vesicle Proteomic Signatures Associated with Pre- and Post-Natal Oxycodone-Exposure.

Authors:  Katherine E Odegaard; Gabriel Gallegos; Sneh Koul; Victoria L Schaal; Neetha N Vellichirammal; Chittibabu Guda; Andrea P Dutoit; Steven J Lisco; Sowmya V Yelamanchili; Gurudutt Pendyala
Journal:  Cells       Date:  2022-05-25       Impact factor: 7.666

Review 4.  Positive Social Interactions in a Lifespan Perspective with a Focus on Opioidergic and Oxytocinergic Systems: Implications for Neuroprotection.

Authors:  Valentina Colonnello; Nicola Petrocchi; Marina Farinelli; Cristina Ottaviani
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  Spatiotemporal Up-Regulation of Mu Opioid Receptor 1 in Striatum of Mouse Model of Huntington's Disease Differentially Affecting Caudal and Striosomal Regions.

Authors:  Ryoma Morigaki; Jannifer H Lee; Tomoko Yoshida; Christian Wüthrich; Dan Hu; Jill R Crittenden; Alexander Friedman; Yasuo Kubota; Ann M Graybiel
Journal:  Front Neuroanat       Date:  2020-12-10       Impact factor: 3.856

6.  Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice.

Authors:  C Cinque; S Pondiki; D Oddi; M G Di Certo; S Marinelli; A Troisi; A Moles; F R D'Amato
Journal:  Transl Psychiatry       Date:  2012-08-28       Impact factor: 6.222

Review 7.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.